US Patent

US10086156 — Dose counter for inhaler and method for counting doses

Formulation · Assigned to Teva Pharmaceuticals Ireland · Expires 2031-05-18 · 5y remaining

Vulnerability score 31/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a dose counter for a metered dose inhaler that counts doses as the canister is used.

USPTO Abstract

A dose counter for a metered dose inhaler includes an incremental counting system for counting doses. The incremental counting system has a main body, an actuator arranged to be driven in response to canister motion and to drive an incremental output member in response to canister motion. The actuator and incremental output member are configured to have predetermined canister fire and count configurations in a canister fire sequence. The canister fire configuration is determined by a position of the actuator relative to a datum at which the canister fires medicament and the count configuration is determined by a position of the actuator relative to the datum at which the incremental count system makes an incremental count. The actuator is arranged to reach a position in the count configuration at or after a position in the canister fire configuration.

Drugs covered by this patent

Patent Metadata

Patent number
US10086156
Jurisdiction
US
Classification
Formulation
Expires
2031-05-18
Drug substance claim
No
Drug product claim
Yes
Assignee
Teva Pharmaceuticals Ireland
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.